Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT04115826
Other study ID # 19-0402
Secondary ID
Status Enrolling by invitation
Phase N/A
First received
Last updated
Start date January 2, 2020
Est. completion date June 30, 2026

Study information

Verified date May 2024
Source University of Colorado, Denver
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a multi-center randomized controlled trial comparing extracorporeal shock-wave lithotripsy (ESWL) with per-oral pancreatoscopy-guided lithotripsy (PPL) in the treatment of patients with chronic pancreatitis and refractory main pancreatic duct stones. This study will be comparing the two treatment options for patients who have stones that fail initial endoscopic therapy via endoscopic retrograde pancreatography (ERCP). The study will look at the stone clearance rates and patient-centered outcomes including quality of life and pain.


Description:

Patients with chronic pancreatitis frequently develop obstructing pancreatic duct stones which can lead to severe pain. Current standard methods to remove these stones include ERCP and extracorporeal shock-wave lithotripsy (ESWL) which are limited in removing larger and multiple impacted stones. Availability in the USA of ESWL for this indication also may be limited even at major referral centers. The introduction of single-operator per-oral pancreatoscopy (SpyGlassTM) has enabled direct intraductal visualization to target stones. Retrospective studies demonstrate a high success rate but literature is quite limited, uncontrolled, and highly selective. Further, many experts and recent European Society Guidelines suggest that ESWL is the only primary therapy for larger stones (5mm or larger) and that intraductal endoscopy and lithotripsy should only be used for 'salvage' therapy in select patients. A critical need exists to compare the efficacy of per oral pancreatoscopy-guided lithotripsy (PPL) with ESWL to determine which therapy is most efficacious in removing refractory PD stones. The investigators believe ERCP with POP has distinct advantages of localizing 'shocks' to the stones, helping to identify and treat underlying strictures in the duct, and lithotripsy of multiple stones can be performed at a single session with a recent multi-center international retrospective study showing all stones removed in a single session in over 70% of cases. Therefore, this project seeks to change the perceived standard of care as it relates to symptomatic pancreatic duct stones in this population, shifting the pendulum towards endoscopic and specifically pancreatoscopy-guided therapy.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 150
Est. completion date June 30, 2026
Est. primary completion date March 31, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years to 89 Years
Eligibility Inclusion Criteria: 1. Subjects aged 18-89 2. Subjects with abdominal pain secondary to chronic calcific pancreatitis and main pancreatic duct stones found on cross-sectional imaging, EUS, or ERP with upstream PD dilation 3. Main PD stones in the head or body that are greater than 50% in size of the immediate downstream diameter of the pancreatic duct 4. Stones = 5 mm in diameter or impacted in the main PD on cross-sectional imaging or EUS Exclusion Criteria: 1. Subjects who have previously received PPL or ESWL for PD stones within 12 months of enrollment 2. Patients with PD stones isolated in the tail or side branches of the main duct 3. Pancreatic tail stones comprising more than one-third of the stone burden within the main PD, if multiple locations of stones are noted within the main PD 4. Nontraversable ansa loop with upstream stones 5. Inability to place a transpapillary pancreatic duct stent during ERP 6. Patients with prior pancreatic surgery or surgically altered gastroduodenal anatomy, such as Roux-en-Y surgery 7. Acquired pancreas divisum 8. Significant cardiopulmonary co-morbidities precluding general anesthesia 9. Patients with coagulation disorders that cannot be corrected to an INR below 2.0 10. Patients with ongoing alcohol abuse and/or illicit drug use, except products containing THC 11. Pregnancy 12. Patients in active treatment for malignancy other than non-melanoma skin cancer or papillary thyroid cancer

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Per-oral Pancreatoscopy-guided Lithotripsy
Per-oral Pancreatoscopy-guided lithotripsy will be administered for a maximum of 4 sessions (1 hour max per session). Either electrohydraulic lithotripsy or laser lithotripsy will be allowed during the session at the discretion of the endoscopist.
Extracorporeal Shock-Wave Lithotripsy
ESWL will then be performed with the patient in either slight left or right lateral decubitus with shock waves entering the body from the ventral side. The shockwaves will be focused first on the most distally located stone within the main duct and then on other calculi moving from the head towards the body. If a stent has been inserted during preceding ERP then this may also serve as a guide to target main pancreatic duct stones by ESWL. A total of one hour of ESWL at a rate of 60-120 shocks/minute will be delivered in one treatment session.

Locations

Country Name City State
United States University of Colorado Anschutz Medical Campus Aurora Colorado

Sponsors (1)

Lead Sponsor Collaborator
University of Colorado, Denver

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Stone Clearance Rate The rate of complete clearance of the main pancreatic duct of all stones. Up to 4 hours (four 1-hour sessions)
Secondary Change In Quality of Life as Measured Using PANQOLI Score Change in quality of life as measured using the PANQOLI (PANcreatitis Quality of Life Instrument), a chronic pancreatitis-specific quality of life instrument. This instrument has a score range from 0 to 100, which higher scores denoting better quality of life. The questionnaire has 18 items and questions 1, 2, 3, 4, 5, 6, 12, 13, 14, 15, 16, 17, and 18 are reverse scored while items 7, 8, 9, 10, and 11 are scored at face value. The final score is the sum of the scores from all 18 questions. At the conclusion of treatment success/failure at 1,3,6, and 12 months follow-up
Secondary Change in Pain Levels as Measured Using the COMPAT Score Change in pain levels as measured using the comprehensive pain assessment tool, (COMPAT), a chronic pancreatitis-specific pain questionnaire. The questionnaire consists of 23 questions. A score is assessed for question # 14, which consists of 28 questions with scores ranging from 0 to 10, with 10 representing worse pain. A maximum score of 280 is possible for this component of the COMPAT. At the conclusion of treatment success/failure at 1,3,6, and 12 months follow-up
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05326542 - Comparison of Efficacy of ESWL and Laser Lithotripsy in Chronic Pancreatitis With ERCP N/A
Completed NCT01551511 - Δ9-THC (Namisol®) in Chronic Pancreatitis Patients Suffering From Persistent Abdominal Pain Phase 2
Completed NCT01731821 - Nonstented Stump-closed vs Duct-to-Mucosa Pancreaticojejunostomy After Pancreaticoduodenectomy Phase 3
Active, not recruiting NCT05095831 - EUS Shear Wave for Solid Pancreatic Lesions.
Completed NCT03173118 - Elastography in the Diagnosis of Chronic Pancreatitis N/A
Terminated NCT01318590 - Prospective Study on Endoscopic Ultrasound (EUS) Celiac Bloc Efficacy in Chronic Pancreatitis Phase 3
Recruiting NCT05772234 - Aggressive Intravenous Hydration With Lactated Ringer's Solution for Prevention of Post-ESWL Pancreatitis N/A
Recruiting NCT04131010 - Digital Catheter Based Pancreatoscopy (SpyGlassDS) for the Management of Symptomatic Pancreatic Duct Stones in Selected Patients With Chronic Pancreatitis N/A
Terminated NCT00359320 - A Randomized Trial of Two Surgical Techniques for Pancreaticojejunostomy in Patients Undergoing Pancreaticoduodenectomy N/A
Completed NCT02940067 - Enhancing Fitness Before Pancreatic Surgery N/A
Recruiting NCT05261997 - Endotherapy for Painless Chronic Pancreatitis N/A
Not yet recruiting NCT05270434 - Optimal Timing of Endoscopic Intervention in the Treatment of Chronic Pancreatitis. N/A
Completed NCT03672422 - Pediatric Longitudinal Cohort Study of Chronic Pancreatitis
Enrolling by invitation NCT05287737 - Clinical Outcome After Total Pancreatectomy With Islet Autotransplantation
Not yet recruiting NCT06426160 - Tocilizumab for Painful Chronic Pancreatitis Phase 2
Enrolling by invitation NCT05289362 - Comparison of Efficacy of Basket and Balloon in the Removal of Pancreatic Duct Stones in Chronic Pancreatitis Under ERCP N/A
Not yet recruiting NCT04760847 - Intermittent Fasting for Pancreatitis N/A
Enrolling by invitation NCT03228095 - Volatiles in Breath and Headspace Analysis - Diagnostic Markers
Completed NCT00956839 - Prospective Study of Efficacy of Intra-muscular Vitamin D3 in Tropical Calcific Pancreatitis Phase 4
Completed NCT00676702 - A Study of the Enzyme Activity and Safety of Pancrelipase in Patients With Severe Exocrine Pancreatic Insufficiency (EPI) Phase 1